Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 51, 2021 - Issue 12
211
Views
5
CrossRef citations to date
0
Altmetric
Topics in Xenobiochemistry

Meeting report: 3rd workshop of the peptide ADME discussion group

, &
Pages 1470-1474 | Received 08 Dec 2021, Accepted 15 Dec 2021, Published online: 27 Dec 2021
 

Abstract

Challenges and opportunities within peptide ADME (absorption, distribution, metabolism and elimination) were presented and discussed at the 3rd online workshop of the Peptide ADME Discussion Group (3rd of February 2021). This article summarises the presentations and discussions from this workshop.

The following topics were covered:

  • Peptide drug-drug interactions

  • Impact of septic shock on PK and PD of the peptide selepressin

  • MS processing software for metabolite identification of peptides

  • Profiling of peptides in preclinical drug development

  • Strategy for immunogenicity testing of peptides

  • In vitro stability testing of peptides for inhalation and automated LC-MS

Acknowledgements

The organisers thank all speakers for their contributions, and to all participants for fruitful discussions. The authors acknowledge also the DMDG organising and technical team, in particular Stuart Hex and Chris Barron (AssociAction Enterprises).

Disclosure statement

The authors declare no conflict of interest, financial or otherwise.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.